Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia - PubMed (original) (raw)

Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia

S E Arnold et al. Proc Natl Acad Sci U S A. 1991.

Abstract

A variety of cytoarchitectural disturbances have been described in limbic regions in postmortem studies of schizophrenia, many of which suggest a developmental disturbance of normal neuronal geometry. This geometry is established and maintained by elements of the neuronal cytoskeleton. Immunohistochemistry with a panel of 15 monoclonal antibodies was used to monitor the presence of neuronal cytoskeletal proteins in the hippocampal formations of six patients with schizophrenia, six normal controls, and six with neurodegenerative disorders. In five of the six subjects with schizophrenia, prominent and specific alterations were found in the distribution of two microtubule-associated proteins, MAP2 and MAP5, which were anatomically selective for the subiculum and entorhinal cortex. In contrast, the immunoreactivity of other cytoskeletal proteins (i.e., tau, tubulins, and selected neurofilament protein phosphoisoforms) was similar for all subjects. Defects in the expression of MAP2 and MAP5, two proteins that contribute to the establishment and maintenance of neuronal polarity, could underlie some of the cytoarchitectural abnormalities described in schizophrenia and impair signal transduction in the affected dendrites. The subiculum and entorhinal cortex interconnect the hippocampal formation with widespread cortices and subcortical nuclei and play important roles in higher cognitive functions. Hence, pathologic lesions that distort the polarized geometry of neurons could play a role in the emergence of aberrant behavior in schizophrenia.

PubMed Disclaimer

Cited by

Disrupted-in-schizophrenia 1 (DISC1) regulates dysbindin function by enhancing its stability.
Lee SA, Kim SM, Suh BK, Sun HY, Park YU, Hong JH, Park C, Nguyen MD, Nagata K, Yoo JY, Park SK. Lee SA, et al. J Biol Chem. 2015 Mar 13;290(11):7087-96. doi: 10.1074/jbc.M114.614750. Epub 2015 Jan 29. J Biol Chem. 2015. PMID: 25635053 Free PMC article.
Schizophrenia: an integrative approach to modelling a complex disorder.
Robertson GS, Hori SE, Powell KJ. Robertson GS, et al. J Psychiatry Neurosci. 2006 May;31(3):157-67. J Psychiatry Neurosci. 2006. PMID: 16699601 Free PMC article. Review.
Very poor outcome schizophrenia: clinical and neuroimaging aspects.
Mitelman SA, Buchsbaum MS. Mitelman SA, et al. Int Rev Psychiatry. 2007 Aug;19(4):345-57. doi: 10.1080/09540260701486563. Int Rev Psychiatry. 2007. PMID: 17671868 Free PMC article. Review.
Assessing declarative memory in schizophrenia using Wisconsin Card Sorting Test stimuli: the Paired Associate Recognition Test.
Ragland JD, Censits DM, Gur RC, Glahn DC, Gallacher F, Gur RE. Ragland JD, et al. Psychiatry Res. 1996 Mar 29;60(2-3):135-45. doi: 10.1016/0165-1781(96)02811-9. Psychiatry Res. 1996. PMID: 8723304 Free PMC article.
What happens in the brain of schizophrenia patients?: an investigation from the viewpoint of neuropathology.
Iritani S. Iritani S. Nagoya J Med Sci. 2013 Feb;75(1-2):11-28. Nagoya J Med Sci. 2013. PMID: 23544264 Free PMC article. Review.

References

1. Biochemistry. 1976 Oct 5;15(20):4497-505 - PubMed
1. Ann N Y Acad Sci. 1986;466:145-66 - PubMed
1. Biol Psychiatry. 1984 Dec;19(12):1601-21 - PubMed
1. Proc Natl Acad Sci U S A. 1985 Sep;82(17):6006-9 - PubMed
1. Arch Gen Psychiatry. 1986 Jan;43(1):31-5 - PubMed

Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia - PubMed (original) (raw)